Step aside, semaglutide—retatrutide is showing the most impressive weight loss results of any obesity drug to date.

In addition, the obesity drug also improved knee pain in participants, Eli Lilly noted. ・Seven additional Phase 3 trials for ...

Congress has the power to make obesity treatment and weight management accessible to the communities that need it.

Amid soaring global demand for glucagon-like peptide-1 (GLP-1) medications and widespread concerns about affordability and access, the World Health Organization (WHO) released its global comprehensive ...

Bariatric surgery is more cost-effective than GLP-1 RAs for obesity treatment, with lower long-term costs and greater weight loss outcomes. The study found that bariatric surgery led to fewer ...

Northwell Health reports that "Ozempic face" describes the facial changes from rapid weight loss using Ozempic, highlighting ...

Although still in Phase I, Wave Life Sciences’ injectable RNA weight loss treatment achieved results that impressed analysts, ...

GMA is an incisionless, minimally invasive endoscopic procedure. It targets the gastric fundus, the main site of ghrelin production – the so-called hunger hormone. By reducing ghrelin levels, patients ...

The advertiser paid a fee to promote this sponsored article and may have influenced or authored the content. The views expressed in this article are those of the advertiser and do not necessarily ...

Mississippi is bracing for a surge in obesity rates — and launching new programs, policies and school initiatives to fight ...

Bariatric embolization — in which one or more arteries to the stomach are blocked with microspheres — led to promising 1-year weight-loss in a pilot study of 20 patients with severe obesity. In animal ...